-
Cho and colleagues studied 47 women with ultrasound-proven adenomyosis over a 3-year time period.
-
Often there are articles in the ultrasound literature that have diagnostic implications extending far past the ultrasound findings that were the centerpieces of these papers.
-
In This Issue: Guidelines for prediabetes from The American College of Endocrinology; statins for the prevention of dementia? Possible help for women suffering from sexual side effects while on antidepressants; government incentives for electronic prescribing; FDA Actions.
-
The very first step to becoming accredited is to collect all of your institution's policies and procedures related to the human research protection program in a searchable electronic format, an expert advises.
-
The growing field of biobanking has added new wrinkles to issues of withdrawal from research. Withdrawing from participation in a biobank or a large cohort study is a very different matter from withdrawing from a clinical trial. Because of the technology involved, it may not be possible to completely remove one's information from the research.
-
Two or more IRBs reviewing the same study might reach strikingly different conclusions about the study's risks and suitability for human subjects.
-
-
Every study participant has seen some variation of this assurance in informed consent documents: "You are free to participate in this research or to withdraw at any time without penalty or loss of benefits you are entitled to receive."
-
From a bioethical perspective, payments to research participants are complicated, an expert says.
-
Ethicists and others continue to find it troubling that payments to research participants are part of the recruitment process.
